-
1
-
-
77952300630
-
Survival after hepatic resection for metastatic colorectal cancer: Trends in outcomes for 1, 600 patients during two decades at a single institution
-
House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1, 600 patients during two decades at a single institution. J Am Coll Surg. 2010; 210: 744-52, 52-5.
-
(2010)
J Am Coll Surg
, vol.210
-
-
House, M.G.1
Ito, H.2
Gonen, M.3
-
2
-
-
34250173120
-
Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy
-
Kornprat P, Jarnagin WR, Gonen M, et al. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol. 2007; 14: 1151-60.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 1151-1160
-
-
Kornprat, P.1
Jarnagin, W.R.2
Gonen, M.3
-
3
-
-
35648981122
-
Actual 10-year survival after resection of colorectal liver metastases defines cure
-
Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007; 25: 4575-80.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4575-4580
-
-
Tomlinson, J.S.1
Jarnagin, W.R.2
DeMatteo, R.P.3
-
4
-
-
0043167985
-
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis
-
discussion 41-2
-
Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 2003; 197: 233-41; discussion 41-2.
-
(2003)
J Am Coll Surg
, vol.197
, pp. 233-241
-
-
Martin, R.1
Paty, P.2
Fong, Y.3
-
5
-
-
36349027540
-
Simultaneous resections of colorectal cancer and synchronous liver metastasis: A multi-institutional analysis
-
Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastasis: a multi-institutional analysis. Ann Surg Oncol. 2007; 14: 3481-91.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 3481-3491
-
-
Reddy, S.K.1
Pawlik, T.M.2
Zorzi, D.3
-
6
-
-
84878864666
-
Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis
-
Tzeng CS, Aloia TA, Vauthey JN, et al. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013; 20: 482-90.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 482-490
-
-
Tzeng, C.S.1
Aloia, T.A.2
Vauthey, J.N.3
-
7
-
-
70249148634
-
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment
-
Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009; 27: 3379-84.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3379-3384
-
-
Poultsides, G.A.1
Servais, E.L.2
Saltz, L.B.3
-
8
-
-
84872201863
-
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: Expert consensus statements
-
Abdalla EK, Bauer TW, Chun YS, et al. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford). 2013; 15: 119-30.
-
(2013)
HPB (Oxford)
, vol.15
, pp. 119-130
-
-
Abdalla, E.K.1
Bauer, T.W.2
Chun, Y.S.3
-
9
-
-
84890567641
-
Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: Long-term results over a 10-year period
-
Sep 3 [Epub ahead of print]
-
Gruber-Rouh T, Naguib NN, Eichler K, et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer. Sep 3 2013. [Epub ahead of print].
-
(2013)
Int J Cancer
-
-
Gruber-Rouh, T.1
Naguib, N.N.2
Eichler, K.3
-
10
-
-
84858699403
-
Yttrium-90 radioembolization for colorectal cancer liver metastases: A single institution experience
-
Nace GW, Steele JL, Amesur N, et al. Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol. 2011; 2011: 571261.
-
(2011)
Int J Surg Oncol
, vol.2011
, pp. 571261
-
-
Nace, G.W.1
Steele, J.L.2
Amesur, N.3
-
11
-
-
40749149728
-
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial
-
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008; 22: 1007-16.
-
(2008)
Lancet
, vol.22
, pp. 1007-1016
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
-
12
-
-
84862999938
-
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
-
Misale S, Yaeger R, Hobor S, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012; 486: 532-6.
-
(2012)
Nature
, vol.486
, pp. 532-536
-
-
Misale, S.1
Yaeger, R.2
Hobor, S.3
-
13
-
-
64649092523
-
Patients with initially unresectable colorectal liver metastases: Is there a possibility of cure?
-
Adam R, Wicherts DA, de Haas RJ, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 2009; 27: 1829-35.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1829-1835
-
-
Adam, R.1
Wicherts, D.A.2
de Haas, R.J.3
-
14
-
-
34548160680
-
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803
-
Saltz LB, Niedzwiecki D, Hollis D, et al. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. J Clin Oncol. 2007; 25: 3456-61.
-
(2007)
J Clin Oncol
, vol.25
, pp. 3456-3461
-
-
Saltz, L.B.1
Niedzwiecki, D.2
Hollis, D.3
-
15
-
-
63549145899
-
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
-
Ychou M, Raoul J-L, Douillard J-Y, et al. A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Ann Oncol. 2009; 20: 674-80.
-
(2009)
Ann Oncol
, vol.20
, pp. 674-680
-
-
Ychou, M.1
Raoul, J.-L.2
Douillard, J.-Y.3
-
16
-
-
67650290547
-
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
-
Van Cutsem E, Labianca R, Bodoky G, et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol. 2009; 27: 3117-25.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3117-3125
-
-
Van Cutsem, E.1
Labianca, R.2
Bodoky, G.3
-
17
-
-
70449105423
-
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
-
Ychou M, Hohenberger W, Thezenas S, et al. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol. 2009; 20: 1964-70.
-
(2009)
Ann Oncol
, vol.20
, pp. 1964-1970
-
-
Ychou, M.1
Hohenberger, W.2
Thezenas, S.3
-
18
-
-
69549147378
-
A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
-
abstr LBA4
-
Wolmark N, Yothers G, O'Connell MJ, et al. A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08. J Clin Oncol. 2009; 27(suppl): abstr LBA4.
-
(2009)
J Clin Oncol
, vol.27
, Issue.SUPPL.
-
-
Wolmark, N.1
Yothers, G.2
O'Connell, M.J.3
-
19
-
-
84870244259
-
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): A phase 3 randomised controlled trial
-
de Gramont A, Van Cutsem E, Schmoll H-J, et al. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. Lancet Oncol. 2012; 13: 1225-33.
-
(2012)
Lancet Oncol
, vol.13
, pp. 1225-1233
-
-
de Gramont, A.1
Van Cutsem, E.2
Schmoll, H.-J.3
-
20
-
-
42949149159
-
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study
-
Saltz LB, Clarke S, Diaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008; 26: 2013-19.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2013-2019
-
-
Saltz, L.B.1
Clarke, S.2
Diaz-Rubio, E.3
-
21
-
-
84859403854
-
Effects of oxaliplatin, 5-fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: A randomized trial
-
Alberts SR, Sargent DJ, Nair S, et al. Effects of oxaliplatin, 5-fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA. 2012; 307: 1383-93.
-
(2012)
JAMA
, vol.307
, pp. 1383-1393
-
-
Alberts, S.R.1
Sargent, D.J.2
Nair, S.3
-
22
-
-
42649145667
-
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
-
Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008; 26: 1626-34.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1626-1634
-
-
Amado, R.G.1
Wolf, M.2
Peeters, M.3
-
24
-
-
84885447848
-
A randomized clinical trial of chemotherapy compared to chemotherapy in combination with cetuximab in k-RAS wild-type patients with operable metastases from colorectal cancer: The new EPOC study
-
abstr 3504
-
Primrose J, Falk S, Finch-Jones M, et al. A randomized clinical trial of chemotherapy compared to chemotherapy in combination with cetuximab in k-RAS wild-type patients with operable metastases from colorectal cancer: the new EPOC study. J Clin Oncol. 2013; 31(suppl): abstr 3504.
-
(2013)
J Clin Oncol
, vol.31
, Issue.SUPPL.
-
-
Primrose, J.1
Falk, S.2
Finch-Jones, M.3
-
25
-
-
6044226542
-
Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
German Rectal Cancer Study Group
-
Sauer R, Becker H, Hohenberger W, et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351: 1731-40.
-
(2004)
N Engl J Med
, vol.351
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
-
26
-
-
79957978117
-
Complete pathologic response in the primary of rectal or colon cancer treated with FOLFOX without radiation
-
abstr 3649
-
Cercek A, Weiser MR, Goodman KA, et al. Complete pathologic response in the primary of rectal or colon cancer treated with FOLFOX without radiation. J Clin Oncol. 2010; 28(suppl): abstr 3649.
-
(2010)
J Clin Oncol
, vol.28
, Issue.SUPPL.
-
-
Cercek, A.1
Weiser, M.R.2
Goodman, K.A.3
-
27
-
-
77956662920
-
Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer
-
abstr 434
-
Schrag D, Weiser MR, Goodman KA, et al. Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer. J Clin Oncol. 2010; 28(suppl): abstr 434.
-
(2010)
J Clin Oncol
, vol.28
, Issue.SUPPL.
-
-
Schrag, D.1
Weiser, M.R.2
Goodman, K.A.3
-
28
-
-
84867846221
-
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer
-
Butte JM, Gonen M, Ding P, et al. Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer. 2012; 118: 5414-23.
-
(2012)
Cancer
, vol.118
, pp. 5414-5423
-
-
Butte, J.M.1
Gonen, M.2
Ding, P.3
-
29
-
-
0035975394
-
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
-
Dutch Colorectal Cancer Group
-
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345: 638-46.
-
(2001)
N Engl J Med
, vol.345
, pp. 638-646
-
-
Kapiteijn, E.1
Marijnen, C.A.2
Nagtegaal, I.D.3
-
30
-
-
84883802248
-
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer
-
van Dijk TH, Tamas K, Beukema JC, et al. Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. Ann Oncol. 2013; 24: 1762-9.
-
(2013)
Ann Oncol
, vol.24
, pp. 1762-1769
-
-
van Dijk, T.H.1
Tamas, K.2
Beukema, J.C.3
|